Acorda Therapeutics (United States)

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

Andrew Goodman, Theodore R. Brown, Lauren Krupp et al. · The Lancet · 2009 · 547 citations

Sustained-release Oral Fampridine, Neurological Disorder, Clinical Neurology +8

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

Andrew Goodman, Theodore R. Brown, Keith R. Edwards et al. · Annals of Neurology · 2010 · 371 citations

Non-cell-autonomous cancer progression from chromosomal instability

Jun Li, Melissa J. Hubisz, Ethan M. Earlie et al. · Nature · 2023 · 242 citations · Full text

Chondroitinase ABCI Improves Locomotion and Bladder Function following Contusion Injury of the Rat Spinal Cord

Anthony O. Caggiano, Michael Zimber, Anindita Ganguly et al. · Journal of Neurotrauma · 2005 · 188 citations

Engineering, Peripheral Nerve, Biomedical Engineering +17

Dose comparison trial of sustained-release fampridine in multiple sclerosis

Andrew Goodman, Ted R. Brown, J. A. Cohen et al. · Neurology · 2008 · 178 citations